# Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates diabetic nephropathy via suppressing SLC7A11-mediated ferroptosis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/non-steroidal-mineralocorticoid-receptor-antagonist-finerenone-ameliorates/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lu Yu,Zihan Zhai,Yulin Wang,Liuwei Wang,Qiuhong Li,Y H Guo,Yan Liang,Lin Tang |
| Citations | 1 |
| DOI | 10.1016/j.intimp.2026.116448 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W7133121595 |
| PMID | 41763165 |
| Type | article |
| Year | 2026 |

## Paper authors

- [Zihan Zhai](https://scholariq.org/researchers/zihan-zhai/)
- [Y H Guo](https://scholariq.org/researchers/y-h-guo/)
- [Qiuhong Li](https://scholariq.org/researchers/qiuhong-li-2/)

## Paper journal

- [International Immunopharmacology](https://scholariq.org/journals/international-immunopharmacology/)

## Paper primary topic

- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

## Paper topics

- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Cholesterol and Lipid Metabolism](https://scholariq.org/topics/cholesterol-and-lipid-metabolism/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.